BioCatalystWatch
LXEOWorkspace / LXEO / OverviewCompany library
Lexeo Therapeutics, Inc. logo

Lexeo Therapeutics, Inc.

Lexeo Therapeutics, Inc. (LXEO)

Website

Price
Market cap
Next catalystExpected Q4 2026LX2020 — HEROIC-PKP2 · Phase 1/2 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

LX2006

FXN transgene × Frataxin restoration

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

LX2020

PKP2 transgene × PKP2 protein restoration

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

LX2022

TNNI3 transgene

PreINDP1P2P3FilingApproved
Upcoming / outlook

LX2020

PKP2 transgene × PKP2 protein restoration

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

LX2020

PKP2 transgene × PKP2 protein restoration

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

LX2022

TNNI3 transgene

PreINDP1P2P3FilingApproved
Upcoming / outlook

LX2006

FXN transgene × Frataxin restoration

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

LX2020

PKP2 transgene × PKP2 protein restoration

Upcoming / outlook

Other pipelines

HDAC

LX2021

Cx43 transgene × Connexin 43 restoration

LX3030

HDAC

LX3050

TfR1 (delivery receptor)

LX3070

FXN mRNA × TfR1 (delivery receptor)

LX1004

Functional CLN2 transgene × TPP1 protein restoration

PreINDP1P2P3FilingApproved
LX1021

Christchurch-modified APOE2 × Modified APOE protein

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

LXEO PR & News

PR & News

LXEO SEC archive